NCT06972225 Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.
| NCT ID | NCT06972225 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Olivier F. Bertrand |
| Condition | Coronary Arterial Disease (CAD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2025-06-10 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2025-06-10 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.
Eligibility Criteria
Inclusion Criteria: * Adults (\>=18 years of age) * Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025 * Identified in the institutional procedure database Exclusion Criteria: * Incomplete or non-available data on the post-procedural clinical follow-up * Procedures where other devices were used in combination with drug-eluting balloons.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06972225 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Arterial Disease (CAD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06972225 currently recruiting?
Yes, NCT06972225 is actively recruiting participants. Contact the research team at michele.jadin@criucpq.ulaval.ca for enrollment information.
Where is the NCT06972225 trial being conducted?
This trial is being conducted at Québec, Canada.
Who is sponsoring the NCT06972225 clinical trial?
NCT06972225 is sponsored by Olivier F. Bertrand. The trial plans to enroll 1,500 participants.